| ¿µ¹® | vasopressin | ÇÑ±Û | ¹Ù¼ÒÇÁ·¹½Å |
|---|---|---|---|
| ¼³¸í | ½Ã»óÇϺΠ½Å°æÇÙÀÇ ½Å°æ¼¼Æ÷¿¡¼ ¸¸µé¾îÁö¸ç, ³úÇϼöü ÈÄ¿±¿¡ ÀúÀåµÇ´Â 2Á¾ÀÇ È£¸£¸ó ÁßÀÇ Çϳª. Ç×ÀÌ´¢È£¸£¸ó(antidiuretic hormone, ADH)À̶ó°íµµ ÇÑ´Ù. ´Ù¸¥ 1Á¾Àº ¿Á½ÃÅä½ÅÀÌ´Ù. ¸ð¼¼Ç÷°ü°ú ¼¼µ¿¸ÆÀ» ±¸¼ºÇÏ´Â ÆòȰ±Ù Á¶Á÷ÀÇ ¼öÃàÀ» ÀÚ±ØÇÏ¿© Ç÷¾ÐÀ» »ó½Â½ÃŰ´Â ÀÛ¿ëÀÌ ÀÖ´Ù. âÀÚ±ÙÀ°ÀÇ ¼öÃàÀ» ÀÚ±ØÇϰí, ²ÞƲ¿îµ¿À» Áõ°½Ã۸ç, Àڱÿ¡µµ ¿µÇâÀ» ÁØ´Ù. ¶ÇÇÑ ¿ä¼¼°ü ¿øÀ§ºÎÀÇ »óÇǼ¼Æ÷¿¡ Ư¼öÇÑ ÀÛ¿ëÀ» ÀÏÀ¸ÄÑ, °íÇü¹°ÀÇ Èí¼ö¿Í´Â °ü°è¾øÀÌ ¼öºÐÀÇ ÀçÈí¼ö¸¦ Ç×Áø½ÃÄÑ ¿ÀÁÜÀ» ³óÃà½ÃŲ´Ù. ¹Ù¼ÒÇÁ·¹½ÅÀº ÇÕ¼º¿¡ ÀÇÇØ¼µµ ¸¸µé¾îÁö°í, ¶ÇÇÑ °¡ÃàÀÇ Çϼöü ÈÄ¿±À¸·ÎºÎÅ͵µ ¾ò¾îÁö¸ç, Ç×ÀÌ´¢Á¦·Î¼ ÁÖ»ç¾×À¸·Îµµ »ç¿ëµÈ´Ù. °í¸® ¸ð¾çÀ¸·Î Æú¸®ÆéƼµå°áÇÕÀ» ÀÌ·é´Ù. Æ÷À¯·ù¿¡¼ ±¤¹üÀ§ÇÏ°Ô º¼ ¼ö ÀÖ´Â °ÍÀ¸·Î ÄáÆÏ¿¡¼ ¼öºÐÀÇ ÀçÈí¼ö¸¦ ÃËÁøÇÏ´Â ¹°Áú·Î ÀÛ¿ëÇÑ´Ù. ¸ð¼¼Ç÷°üÀ» ¼öÃà½ÃÄÑ Ç÷¾ÐÀ» ³ôÀÌ´Â ÀÛ¿ëÀÌ ÀÖÀ¸¹Ç·Î ÀúÇ÷¾Ð Ä¡·á¿¡ ÀÌ¿ëµÈ´Ù. |
||
| AVP | abnormal vasopressin; actinomycin-vincristine-Platinol; ambulatory venous pressure; antiviral protei... |
|---|---|
| DDAVP, dDAVP | 1-deamino-8-D-arginine vasopressin; 1-deamino-8-N-arginine vasopressin |
| AChRs | Acetylcholine Receptors |
| RA | radioactive; ragocyte; ragweed antigen; rapidly adapting [receptors]; reactive arthritis; reciprocal... |
| ADH | 1) Aldehyde De-Hydrogenase = ALDH 2) Anti-Diur... |
| DDAVP | 1,desamino-8-D-arginine vasopressin |
|---|---|
| AVP | 3)H]arginine vasopressin |
| 3H-AVP | 3H-arginine-vasopressin |
| AVP | 8-Arg]-vasopressin |
| AVP | 8-Arginine vasopressin |
| receptors, vasopressin | Specific molecular sites or structures on or in cells that vasopressins react or to which they bind in order to modify the function of the cells. Two types of vasopressin receptor exist, the v1 receptor and the v2 receptor. The v1 receptor can be subdivided into v1a and v1b (formerly v3) receptors. (12 Dec 1998) |
|---|
| arginine vasopressin | [8-arginine]vasopressin; [Arg8]vasopressin;vasopressin containing an arginyl residue in position 8 (as in chickens and most mammals, including man); porcine vasopressin has a lysyl residue at position 8. All are vasopressors. Synonym: argipressin. (05 Mar 2000) |
|---|---|
| vasopressin | <protein> A peptide hormone released from the posterior pituitary lobe but synthesised in the hypothalamus. There are 2 forms, differing only in the amino acid at position 8: arginine vasopressin is widespread, while lysine vasopressin is found in pigs. Has antidiuretic and vasopressor actions. Used in the treatment of diabetes insipidus. (18 Nov 1997) |
| vasopressin-converting aminopeptidase | <enzyme> Activity found in brain which converts vasopressin into centrally active metabolites Registry number: EC 3.4.11.- Synonym: vp-c aminopeptidase (26 Jun 1999) |
| vasopressin level | This test measures the amount of ADH in the serum. It is used to detect disorders that may affect the level of ADH in the serum. Normal values are: 0 to 4.7 pg/ml. Elevated ADH levels can indicate a CNS infection, fluid imbalance, CNS tumour, SIADH or acute porphyria. Low levels can indicate: diabetes insipidus or damage to the pituitary gland. (27 Sep 1997) |
| vasopressin-resistant diabetes | Diabetes insipidus due to inability of the kidney tubules to respond to antidiuretic hormone; X-linked inheritance, with full expression in males and partial defect in heterozygous females. Synonym: vasopressin-resistant diabetes. (05 Mar 2000) |
| unit of vasopressin | The pressor activity of 0.5 mg of the USP Posterior-pituitary Reference Standard; 1 mg of synthetic vasopressin corresponds to 600 IU. (05 Mar 2000) |
| 8-lysine vasopressin | <chemical> 8-lysyl vasopressin. The porcine antidiuretic hormone most frequently used clinically. A cyclic nonapeptide with lysine in position 8 of the chain; it is used to treat diabetes insipidus and as haemostatic because of its vasoconstrictor action. Pharmacological action: haemostatics, renal agents, vasoconstrictor agents. Chemical name: Vasopressin, 8-L-lysine- (12 Dec 1998) |
| adrenergic receptors | Reactive components of effector tissues, most of which are innervated by adrenergic postganglionic fibres of the sympathetic nervous system. Such receptor's can be activated by norepinephrine and/or epinephrine and by various adrenergic drugs; receptor activation results in a change in effector tissue function, such as contraction of arteriolar muscles or relaxation of bronchial muscles; adrenergic receptor's are divided into alpha-receptor's and beta-receptor's, on the basis of their response to various adrenergic activating and blocking agents. Synonym: adrenoceptor, adrenoreceptors. (05 Mar 2000) |
| alpha-adrenergic receptors | Adrenergic receptor's in effector tissues capable of selective activation and blockade by drugs; conceptually derived from the ability of certain agents, such as phenoxybenzamine, to block only some adrenergic receptor's and of other agents, such as methoxamine, to activate only the same adrenergic receptor's. Such receptor's are designated as alpha-receptors. Their activation results in physiological responses such as increased peripheral vascular resistance, mydriasis, and contraction of pilomotor muscles. (05 Mar 2000) |
| ANP clearance receptors | Cell surface proteins that bind atrial natriuretic peptide and ANP fragments without initiating biological action. (05 Mar 2000) |
| ANP receptors | Cell surface receptors for atrial natriuretic peptide that have a single transmembrane spanning element; these have integral kinase and guanylate cyclase domains. (05 Mar 2000) |
| B-cell antigen receptors | In the primary immune response immunoglobulin D and monomeric immunoglobulin M are the B-cell antigen receptors. On memory B-cells, other immunoglobulin molecules can serve as antigen receptors. (05 Mar 2000) |
| beta-adrenergic receptors | Adrenergic receptor's in effector tissues capable of selective activation and blockade by drugs; conceptually derived from the ability of certain agents, such as propranolol, to block only some adrenergic receptor's and of other agents, such as isoproterenol, to activate only the same adrenergic receptor's. Such receptor's are designated as beta-receptors. Their activation results in physiological responses such as increases in cardiac rate and force of contraction (b1), and relaxation of bronchial and vascular smooth muscle (b2). (05 Mar 2000) |
| mannose-6-phosphate receptors | Receptors in Golgi apparatus to which newly synthesised proteins that are destined to enter lysosomes bind. (05 Mar 2000) |
| receptors, adrenergic | Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of g-proteins with which they bind; this scheme does not respect the alpha-beta distinction. (12 Dec 1998) |
Synonyms : 8-Arg-Vasopressin Receptor, Antidiuretic Hormone Receptor, Antidiuretic Hormone Receptor 1a, Antidiuretic Hormone Receptor 1b, Arginine Vasopressin Receptor, Argipressin Receptor, Argipressin Receptors, Receptor, Arginine(8)-Vasopressin, V1 Receptor
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|